baber/WOPTO huggingface dataset:
Patent MX-PA02004469-A (MX)
Title: An improvement in a refrigeration circuit.
Inventor: MARCIO ROBERT THIESSEN
IPC: F25B45/00
Filed: 2000-10-26
Abstract: An improvement in a refrigeration circuit comprising a hermetic chamber (10), which is maintained in fluid communication with the refrigeration circuit, immediately downstream at least one of the parts defined by a condenser (5) and by a hermetic compressor (1), and which is dimensioned to store, in conditions of long stops of the hermetic compressor (1) and of a start thereof, a substantial volume of refrigerant fluid, said hermetic chamber (10) returning to the refrigeration circuit substantially all the refrigerant fluid stored therein, after said conditions have ended.
Patent MX-PA02008365-A (MX)
Title: Mutants of bone morphogenetic proteins.
Inventor: WEBER FRANZ
IPC: C07K14/51
Filed: 2002-08-26
Abstract: The present invention relates to navel mutants of bone morphogenetic proteins (BMPs) useful as inhibitors of heterotopic ossification. Specifically, the present invention relates to novel mutants containing only the entire region involved in the formation of finger 2 including the wrist epitope of a BMP with a specific cysteine residue or specific cysteine residues replaced by a different amino acid. The present invention also relates pharmaceutical compositions containing these mutants and to the use of the mutants and pharmaceutical compositions in therapy.
Patent MX-PA02008432-A (MX)
Title: Whitlockite bioceramic preparation with magnesium at high temperature.
Inventor: PINA BARBA MARIA CRISTINA
IPC: C04B35/00
Filed: 2002-08-29
Abstract: The present invention refers to a method for producing a magnesium-whitlockite ceramic by high-temperatures syntherization to be used as bioceramic in bone repairing, reconstruction or size-increase of it in the form of ceramic blocks or granules. The improvement, in relation to other bioceramics is that its reabsorption is quicker. Its preparation comprises the following steps: a) constitution of the compounds; b) preparation of a mixture; c) preparation of a humid atmosphere; d) heating at high temperatures; e) cooling until reaching ambient temperature.
Patent MX-PA02009291-A (MX)
Title: Oxygen reduced niobium oxides.
Inventor: KIMMEL JONATHON L
IPC: H01G9/042
Filed: 2001-03-22
Abstract: Methods to at least partially reduce a niobium oxide are described wherein the process includes heat treating the niobium oxide in the presence of a getter material and in an atmosphere which permits the transfer of oxygen atoms from the niobium oxide to the getter material, and for a sufficient time and at a sufficient temperature to form an oxygen reduced niobium oxide. Niobium oxides and or suboxides are also described as well as capacitors containing anodes made from the niobium oxides and suboxides. Anodes formed from niobium oxide powders using binders and or lubricants are described as well as methods to form the anodes.
Patent MX-PA02009924-A (MX)
Title: Unique compositions of zwitterionic phospholipids and bisphosphonates and use of the compositions as bisphosphate delivery systems with reduced gi toxicity.
Inventor: LICHTENBERGER LENARD M
IPC: A61K31/675
Filed: 2001-04-06
Abstract: Compositions and methods for treating osteoporosis using the compositions are disclosed where the compositions have reduced GI toxicity and improved bio availability and include a bisphosphonate and zwitterionic phospholipid.
Patent MX-PA02012208-A (MX)
Title: Electrophotographic development system with custom color printing.
Inventor: BRAY DANIEL M
IPC: G03G15/08
Filed: 2002-12-10
Abstract: An apparatus for developing a latent image recorded on an imaging surface with a custom color toner, including a developer housing for developing a portion of said latent image with the toner of custom color. The developer housing includes a donor member for transporting toner of the custom color to a development zone to develop the latent image. A replaceable reservoir unit is provided for mixing and supplying the custom color toner to the donor member. An array of toner dispensers is provided for supplying various primary color toners, as required, to achieve the custom color, and additional reservoirs having various colored toners therein to allow for faster convergence to a given point in the color space.
Patent MX-PA03000539-A (MX)
Title: Flotation mechanism and method for dispersing gas and controlling flow in a flotation cell.
Inventor: NYMAN BROR
IPC: B03D1/16
Filed: 2001-07-19
Abstract: The invention relates to a flotation mechanism (4) comprising a directional element (25) and vertical vanes (26) located in a flotation cell (2). The directional element is symmetrical and is fixed at the centre to the lower section of the hollow shaft of the mechanism. According to the corresponding method, due to the directional element (25), which is cylindrically inclined downwards from the outer edge the flotation mechanism directs the gas-slurry suspension that is formed in a downward slanting direction towards the side wall of the cell. The mineral suspension rises upwards from the side wall towards the centre of the cell, from where the flow is diverted to the edges of the cell and the froth generated is removed from the cell. Using this flotation mechanism enables a powerful agitation, extending throughout the entire mixing zone (I).
Patent MX-PA03000634-A (MX)
Title: Methods for the replacement, translocation and stacking of dna in eukaryotic genomes.
Inventor: OW DAVID W
IPC: C12N15/82
Filed: 2001-07-23
Abstract: The present invention includes compositions and methods for site-specific polynucleotide replacement in eukaryotic cells. These methods include single polynucleotide replacement as well as gene stacking methods. Preferred eukaryotic cells for use in the present invention are plant cells and mammalian cells.
Patent MX-PA03000764-A (MX)
Title: Antimicotic nail varnish composition.
Inventor: MAILLAND FEDERICO
IPC: A61K8/00
Filed: 2001-07-18
Abstract: The present invention relates to a composition comprising a) at least one antimycotic agent and b) at least one film forming agent wherein component b) is a derivative of chitosan selected from hydroxyalkylchitosans and carboxyalkylchitosans and its use as a nail varnish. The present invention is further directed to the use of a water soluble film forming agent selected from hydroxyalkylchitosans and carboxyalkylchitosans as an additive in a nail varnish.
Patent MX-PA03002286-A (MX)
Title: Time-window-constrained multicast for future delivery multicast.
Inventor: PADMANABHAN VENKATA N
IPC: G06F21/62
Filed: 2003-03-14
Abstract: To provide a fairness of distribution, an encrypted event, containing information not intended for release prior to a release time, can be sent to clients prior to the release time. In such a manner the bulk of the information can be transferred to the clients without concern to the duration of the transfer. At the release time, a small decryption key can be sent, either from a central sever, or from multiple server, utilizing multiple network paths to provide for the greatest likelihood that each client will receive the decryption key with a minimum of delay. Each client is thereby provided access to the information at approximately the same time, regardless of the bandwidth available to each client. Additionally, trusted edge servers, that can be trusted not to release information prior to an appropriate time, can send an unencrypted event, or decrypt the encrypted event and send the decrypted event, at a determined time, either prior to or after the release time, such that the decrypted or unencrypted event arrives at the clients that could not store and decrypt the encrypted event at approximately the same time as the key arrives at the other clients. Each client can thus receive the information at approximately the same time, regardless of the client's bandwidth or its ability to store and decrypt information.
Patent MX-PA03004928-A (MX)
Title: Method of determining a chemotherapeutic regimen based on ercc1 and ts expression.
Inventor: DANENBERG KATHLEEN D
IPC: A61K31/282
Filed: 2001-11-09
Abstract: The present invention relates to prognostic methods which are useful in medicine, particularly cancer chemotherapy. The object of the invention to provide a method for assessing TS and/or ERCC1 expression levels in fixed or fixed and paraffin embedded tissues and prognosticate the probable resistance of a patient s tumor to treatment with 5-FU and oxaliplatin-based therapies by examination of the amount of TS and/or ERCC1 mRNA in a patient s tumor cells and comparing it to a predetermined threshold expression level for those genes. More specifically, the invention provides to oligonucleotide primer pairs ERCC1 and TS and methods comprising their use for detecting levels of ERCC1 and TS mRNA, respectively.
Patent MX-PA03009129-A (MX)
Title: A closure.
Inventor: RAMSEY CHRISTOPHER PAUL
IPC: B67D3/00
Filed: 2002-03-05
Abstract: A closure (10) is provided for a water bottle of the type used in conjunction with a water fountain. The closure (10) comprises a body (20) having an open feed cylinder (50) and a sealing cap (30) which is movable between a sealing position and an open position and is adapted to seal the feed cylinder when in a sealing position. The sealing cap is biased towards a sealing position by biasing means which preferably comprise a plastics spring (70) that anchors the sealing cap (30) to the body (20). The form of the spring (70) and the arrangement of the sealing cap (30) and the feed cylinder (50) are such as to minimise and compensate for creep in the plastics material of the spring (70) in use of the closure (10) to ensure resealing of the feed cylinder (50) if and when the water bottle is removed from the water fountain.
Patent MX-PA03010531-A (MX)
Title: Therapeutic use of rank antagonists.
Inventor: DIRK M ANDERSON
IPC: A61P31/04
Filed: 2002-05-17
Abstract: Provided herein are methods of treating various medical conditions that require the formation of new bone by administering an effective amount of a RANK antagonist. Antagonists suitable for use in the subject methods include soluble RANK polypeptides that bind RANKL, antisense oligonucleotides that inhibit RANK activity, antibodies specific for RANK or RANKL and osteoprotegerin.
Patent MX-PA04001696-A (MX)
Title: Trim panel insulator for a vehicle.
Inventor: LEE A STAELGRAEVE
IPC: B60R13/08
Filed: 2002-08-20
Abstract: A trim panel insulator (10) is provided for a vehicle. The insulator includes a nonlaminate acoustical and thermal insulating layer (12) of polymer fiber. The insulator may include a relatively high density, nonlaminate skin (14) of polymer fiber and/or one or more facing layers (16, 20) constructed from various materials.
Patent MX-PA04001890-A (MX)
Title: Casein derived peptides and uses thereof in therapy.
Inventor: SIDELMAN ZVI
IPC: A61P7/04
Filed: 2002-08-29
Abstract: Biologically active peptides that are derived from or are similar to sequences identical with the N-terminus of the S1 fraction of milk casein. These peptides are capable of stimulating and enhancing immune response, protecting against viral infection, normalizing serum cholesterol levels, and stimulating hematopoiesis. The casein-derived peptides are non-toxic and can be used to treat and prevent immune pathologies, hypercholesterolemia, hematological disorders and viral-related diseases.
Patent MX-PA04003009-A (MX)
Title: Shampoo containing a cationic polymer and particles.
Inventor: SANJEEV MIDHA
IPC: A61K8/892
Filed: 2002-10-03
Abstract: The compositions of the present invention relate to improved shampoo compositions having from about from about 5 to about 50 weight percent of a detersive surfactant, at least about 0.1 weight percent of particles having a mean particle size of less than about 300 microns, at least about 0.05 weight percent of a cationic polymer having a molecular weight of from about 10,000 to about 10,000,000 and a charge density from about 0.9 meq/gm to about 7.0 meq/gm, and at least about 20.0 weight percent of an aqueous carrier.
Patent MX-PA04003081-A (MX)
Title: Spindle system, apparatus, and methods for applying spindle apparatus.
Inventor: CHRISTOPHER RICHARD BARHAM
IPC: A47K10/38
Filed: 2002-08-12
Abstract: A system, apparatus and method is shown for collecting data on rolled product usage at a dispensing location by monitoring the amount of product pulled or removed from a roll. In the invention, a spindle assembly (21) may be configured to support a product roll (46). The spindle assembly includes a rotating member (22) in operable connection to the spindle (21). A sensor (23) is connected to the spindle assembly (21). The sensor (23) is capable of detecting one or more parameters of product usage from the roll. Furthermore, the sensor may be configured to measure at least the degree of movement of the rotating member during removal of product from the roll. A recording device (24) also may be provided for receiving data from the sensor (23), the recording device (24) being adapted for receiving and recording data. Data that may be generated, and may be recorded, includes roll product usage data. An electronically controlled system of monitoring product inventory, and/or ordering more product when inventory falls below a predetermined threshold amount is disclosed.
Patent MX-PA04005236-A (MX)
Title: Rotary ultrasonic bonder or processor capable of high speed intermittent processing.
Inventor: JOHN FORD CONDRON
IPC: B23K20/10
Filed: 2002-07-10
Abstract: An ultrasonic processing method and apparatus (20) can include a ratatable, ultrasonic horn member (28) that is operatively joined to an isolation member (42) which has high rigidity. A rotatable anvil member (86) can be cooperatively positioned to provide a selected horn-anvil gap (106), and an automated drive (130) can be connected to an actuator (110), or other transfer device, to automatically adjust the horn-anvil gap (106). An electronic processor (128) can be configured to monitor an intermittent gap force detected from an output provided by a force sensor (126), and can provide a drive signal to the automated drive (130) to thereby adjust the horn-anvil gap (106) to operatively maintain a target, gap force value.
Patent MX-PA04005435-A (MX)
Title: Methods and compositions for sealing an expandable tubular in a wellbore.
Inventor: LANCE E BROTHERS
IPC: E21B33/14
Filed: 2002-11-29
Abstract: Methods and compositions are provided for sealing an expandable tubular in a wellbore wherein the methods basically comprise placing the expandable tubular in the wellbore, placing a resilient sealing composition into the wellbore, expanding the expandable tubular and allowing the sealing composition to set in the wellbore.
Patent MX-PA04005690-A (MX)
Title: Stackab le chair with flexing frame.
Inventor: OGDEN R OLSON
IPC: A47C3/04
Filed: 2004-06-11
Abstract: A stackable chair has supporting side members that comprise two bars that cross one another in non-contacting relation to form a substantially X-shaped configuration, the two bars capable of flexing movement relative to one another, so that the chair can flex in response to the weight and movement of the user.
Patent MX-PA04009721-A (MX)
Title: Chewing gum in powder form and a method of preparation.
Inventor: FABIO ALLASIA
IPC: A23G4/08
Filed: 2003-04-04
Abstract: The subject of the invention is a novel chewing gum in tablet form which can be produced by direct compression of a gum formulation in powder form; the chewing gum thus obtained is characterized by a pleasant chewability which remains unchanged throughout the chewing period without hardening like most conventional chewing gums. The chewing gum in powder form is produced by a method which comprises the following steps: a) mixing of a soft basic gum, i.e. gum base, with at least one sweetener and, optionally, at least one other typical chewing-gum ingredient, at a temperature of between about 35 and 75 DEG C; b) cooling of the mixture thus obtained to a temperature of between about 0 and -40 DEG C and preferably between -10 and -40 DEG C; c) grinding and subsequent screening of the mixture thus obtained to a particle size of less than about 10 mesh; d) optional mixing of the powder thus obtained with at least one anti-agglutination agent; e) optional compression of the mixture thus obtained.
Patent MX-PA05000028-A (MX)
Title: Produrg, medicinal utilization thereof and process for producing the same.
Inventor: OKITA TAKAAKI
IPC: A61P11/00
Filed: 2003-06-20
Abstract: A prodrug with the use of an enzyme showing different enzymatic activities between a drug target site and a site where its side effect is expressed, which has a substituent cleavable with the enzyme and is activated due by cleaving the substituent. As an example of the drug target site, a respiratory organ may be cited, while the heart may be sited as an example of the side effect expression site. As an example of the drug, a bronchodilator may be cited while a glicosidase (for example, beta-glucuronidase) may be cited as an example of the enzyme. As an example of the substituent, a glycosyl group comprising a monosaccharide or an oligosaccharide may be cited. Use of the above enzyme makes it possible to lessen the side effect of a drug having a target site for exerting its effect which is different from a site where its side effect is expressed.
Patent MX-PA05000349-A (MX)
Title: Improved transdermal delivery system.
Inventor: WOLFF HANS-MICHAEL
IPC: A61K31/381
Filed: 2003-07-28
Abstract: An improved Transdermal Delivery System (TDS) comprising a backing layer inert to the components of the matrix, a self-adhesive matrix containing an amine-functional drug and a protective foil or sheet to be removed priorto use, characterized in that the self-adhesive matrix consists of a solid or semi-solid semi-permeable polymer (1)wherein an amine functional drug in its free base form has been incorporated, (2) which is saturated with the aminefunctional drug and contains said drug as a multitude of microreservoirs within the matrix, (3) which is highly permeable for the free base of the amine functional drug, (4) which is impermeable for the protonated form of the amine functional drug, (5) wherein the maximum diameter of the microreservoirs is less than the thickness of the matrix. is provided. Said TDS provides for enhanced flux of the amine functional drug across the TDS/skin interface.
Patent MX-PA05002695-A (MX)
Title: Acetyl 2-hydroxy-1,3 diaminoalkanes.
Inventor: MAILLARD MICHEL
IPC: A61K31/18
Filed: 2003-09-10
Abstract: (I) where variables Z, X, R15, R2, R3, and Rc are defined herein. Compounds disclosed herein are inhibitors of the beta-secretase enzyme and are therefore useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal.
Patent MX-PA05004699-A (MX)
Title: Open coil resistance heater with right and left hand installation capability and method of use.
Inventor: HOWARD H KEITH
IPC: F24D13/00
Filed: 2005-04-29
Abstract: An open coil resistance heater assembly is made for universal mounting between left and right hand installations in an appliance or other equipment. The heater assembly has its coils arranged symmetrically about a bisecting plane of the heater assembly and/or a center line of its terminal assembly aligned with the bisecting plane. The symmetrical coil arrangement and/or bisected terminal assembly allow the heater to be used in right hand or left hand installations.
Patent MX-PA05006045-A (MX)
Title: Method for reducing creep in a gypsum plaster-based element, gypsum plaster-based composition and method for making a gypsum plaster-based element with reduced creep.
Inventor: DANIEL MARTIN
IPC: C04B28/14
Filed: 2003-12-02
Abstract: The invention concerns a method for reducing creep in a gypsum plaster-based element, such as a gypsum plaster board. Said method comprises introducing into the gypsum plaster-based composition, prior to setting and curing thereof, a tartaric acid of one of the salts of tartaric acid, in an amount more than 0.001 wt. % relative to the gypsum plaster-based composition hemihydrate calcium sulphate content. The invention also concerns a gypsum plaster-based composition for such an element. Said composition comprises, in weight percentages relative to the composition hemihydrate calcium sulphate content: 0.003 % to 0.45 % of tartaric acid or one of the salts thereof and 0.05 % to 0.95 % of boric acid or one of the salts thereof. Finally, the invention further concerns a gypsum plaster-based element with reduced creep, obtained by hydraulic setting and curing of the inventive composition, the use of tartaric acid or one of the salts thereof for reducing creep in a gypsum plaster-based element as well as a method for making a gypsum plaster-based element with reduced creep.
Patent MX-PA05008822-A (MX)
Title: Write-once optical recording medium and defect management information management method thereof.
Inventor: SUNG DAE KIM
IPC: G11B11/00
Filed: 2003-10-01
Abstract: A write-once optical recording medium, a method for allocating a defect management area of the write-once optical recording medium, and a method for allocating a spare area of the write-once optical recording medium are provided. A method of managing defects on a write-once optical recording medium having at least one recording layer includes the steps of allocating at least one temporary defect management area having a fixed size and at least one temporary defect management area having a variable size to said optical recording medium, respectively, recording defect management information on the at least one temporary defect management area having a fixed size and the at least one temporary defect management area having a variable size; and using the at least one temporary defect management area having a fixed size and the at least one temporary defect management area having a variable size is provided herein.
Patent MX-PA05009409-A (MX)
Title: System and method for protecting microelectromechanical systems array using structurally reinforced back-plate.
Inventor: CUMMINGS WILLIAM J
IPC: B81B7/02
Filed: 2005-09-02
Abstract: Disclosed is an electronic device utilizing interferometric modulation and a package of the device. The packaged device includes a substrate, an interferometric modulation display array formed on the substrate, and a back-plate. The back-plate is placed over the display array with a gap between the back-plate and the display array. The device further includes reinforcing structures which are integrated with the back-plate. The reinforcing structures add stiffness to the back-plate. The back-plate may have a thickness varying along an edge thereof.
Patent MX-PA05010055-A (MX)
Title: 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders.
Inventor: KENTARO HASHIMOTO
IPC: C07D487/04
Filed: 2004-03-11
Abstract: The present invention relates to a benzenesulfonamide derivative of formula (I), which is useful as an active ingredient of pharmaceutical preparations. The benzenesulfonamide derivatives of the present invention have CCR3 (CC type chemokine receptor) antagonistic activity, and can be used for the prophylaxis and treatment of diseases associated with CCR3 activity, in particular for the treatment of asthma, atopic dermatitis, allergic rhinitis and other inflammatory/immunological disorders. In said formula, X represents O or S; R4 represents formulae (a), (b), (c), (d), (e), (f), (g), (h), (i) or (j), the other substituents are as defined in claim 1.
Patent MX-PA05010515-A (MX)
Title: Treating or preventing hot flashes using prodrugs of gaba analogs.
Inventor: GALLOP MARK A
IPC: A61K31/195
Filed: 2004-03-31
Abstract: Disclosed herein are methods of using prodrugs of GABA analogs and pharmaceutical compositions thereof to treat or prevent hot flashes in humans and pharmaceutical compositions of prodrugs of GABA analogs useful in treating or preventing hot flashes.